• 1
    Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention (update 2010), 2010. Available at Last acessed date 20 March 2012.
  • 2
    National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007;120(5 Suppl):S94S138.
  • 3
    LevyML, Fletcher M, Price DB, Hausen T, Halbert RJ, Yawn BP. International Primary Care Respiratory Group (IPSRG) Guidelines: diagnosis of respiratory diseases in primary care. Prim Care Respir J 2006;15:2034.
  • 4
    British Thoracic Society Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Thorax 2008;63(Suppl 4):iv1iv121.
  • 5
    Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J 2008;31:320325.
  • 6
    Stanford RH, Gilsenan AW, Ziemiecki R, Zhou X, Lincourt WR, Ortega H. Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS). J Asthma 2010;47:257262.
  • 7
    Vermeire PA, Rabe KF, Soriano JB, Maier WC. Asthma control and differences in management practices across seven European countries. Respir Med 2002;96:142149.
  • 8
    Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol 2007;119:14541461.
  • 9
    Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol 2007;120:13601367.
  • 10
    Carlton BG, Lucas DO, Ellis EF, Conboy-Ellis K, Shoheiber O, Stempel DA. The status of asthma control and asthma prescribing practices in the United States: results of a large prospective asthma control survey of primary care practices. J Asthma 2005;42:529535.
  • 11
    Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000;16:802807.
  • 12
    Chapman KR, Ernst P, Grenville A, Dewland P, Zimmerman S. Control of asthma in Canada: failure to achieve guideline targets. Can Respir J 2001;8(Suppl A):35A40A.
  • 13
    Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114:4047.
  • 14
    Luskin AT. Achieving asthma control: the need for risk assessment. Manag Care 2005;14(8 Suppl):1215; discussion 25–27.
  • 15
    FitzGerald JM, Boulet LP, McIvor RA, Zimmerman S, Chapman KR. Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J 2006;13:253259.
  • 16
    McIvor RA, Boulet LP, FitzGerald JM, Zimmerman S, Chapman KR. Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician 2007;53:673677.
  • 17
    Holgate S, Bisgaard H, Bjermer L, Haahtela T, Haughney J, Horne R et al. The Brussels Declaration: the need for change in asthma management. Eur Respir J 2008;32:14331442.
  • 18
    Cypcar D, Busse WW. Steroid-resistant asthma. J Allergy Clin Immunol 1993;92:362372.
  • 19
    Nimmagadda SR, Spahn JD, Leung DY, Szefler SJ. Steroid-resistant asthma: evaluation and management. Ann Allergy Asthma Immunol 1996;77:345355; quiz 355–356.
  • 20
    Kay AB. Pathology of mild, severe, and fatal asthma. Am J Respir Crit Care Med 1996;154(2 Pt 2):S66S69.
  • 21
    Barnes PJ. Corticosteroid resistance in airway disease. Proc Am Thorac Soc 2004;1:264268.
  • 22
    Adcock IM, Ito K. Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue? Curr Opin Pharmacol 2004;4:257262.
  • 23
    Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med 2005;172:149160.
  • 24
    Adcock IM, Ford PA, Bhavsar P, Ahmad T, Chung KF. Steroid resistance in asthma: mechanisms and treatment options. Curr Allergy Asthma Rep 2008;8:171178.
  • 25
    Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011;66:910917.
  • 26
    Thomas M, McKinley RK, Freeman E, Foy C. Prevalence of dysfunctional breathing in patients treated for asthma in primary care: cross sectional survey. BMJ 2001;322:10981100.
  • 27
    Johansson A, Bramerson A, Millqvist E, Nordin S, Bende M. Prevalence and risk factors for self-reported odour intolerance: the Skovde population-based study. Int Arch Occup Environ Health 2005;78:559564.
  • 28
    Johansson A, Millqvist E, Nordin S, Bende M. Relationship between self-reported odor intolerance and sensitivity to inhaled capsaicin: proposed definition of airway sensory hyperreactivity and estimation of its prevalence. Chest 2006;129:16231628.
  • 29
    Bai J, Peat J, Berry G, Marks G, Woolcock A. Questionnaire items that predict asthma and other respiratory conditions in adults. Chest 1998;114:13431348.
  • 30
    Ringsberg KC, Bjarneman P, Lowhagen O, Oden A, Toren K. Differences in trigger factors and symptoms between patients with asthma-like symptoms and patients with asthma: development of a basis for a questionnaire. Respir Med 2002;96:305311.
  • 31
    Sistek D, Tschopp JM, Schindler C, Brutsche M, Ackermann-Liebrich U, Perruchoud AP et al. Clinical diagnosis of current asthma: predictive value of respiratory symptoms in the SAPALDIA study. Swiss Study on Air Pollution and Lung Diseases in Adults. Eur Respir J 2001;17:214219.
  • 32
    Pekkanen J, Pearce N. Defining asthma in epidemiological studies. Eur Respir J 1999;14:951957.
  • 33
    Schwartzstein RM, Simon PM, Weiss JW, Fencl V, Weinberger SE. Breathlessness induced by dissociation between ventilation and chemical drive. Am Rev Respir Dis 1989;139:12311237.
  • 34
    Manning HL, Schwartzstein RM. Respiratory sensations in asthma: physiological and clinical implications. J Asthma 2001;38:447460.
  • 35
    Nishino T. Dyspnoea: underlying mechanisms and treatment. Br J Anaesth 2011;106:463474.
  • 36
    Manning HL, Schwartzstein RM. Pathophysiology of dyspnea. N Engl J Med 1995;333:15471553.
  • 37
    Scano G, Stendardi L, Grazzini M. Understanding dyspnoea by its language. Eur Respir J 2005;25:380385.
  • 38
    Simon PM, Schwartzstein RM, Weiss JW, Lahive K, Fencl V, Teghtsoonian M et al. Distinguishable sensations of breathlessness induced in normal volunteers. Am Rev Respir Dis 1989;140:10211027.
  • 39
    Simon PM, Schwartzstein RM, Weiss JW, Fencl V, Teghtsoonian M, Weinberger SE. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990;142:10091014.
  • 40
    Taguchi O, Kikuchi Y, Hida W, Iwase N, Satoh M, Chonan T et al. Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea. J Appl Physiol 1991;71:21832190.
  • 41
    Gandevia SC, Killian KJ, Campbell EJ. The effect of respiratory muscle fatigue on respiratory sensations. Clin Sci (Lond) 1981;60:463466.
  • 42
    Lougheed D, Webb K, O'Donell D. Breathlessness during induced lung hyperinflation in asthma: the role of the inspiratory threshold load. Am J Respir Crit Care Med 1995;152:911920.
  • 43
    Lougheed M, Fissher T, O'Donnell D. Dynamic hyperinflation during bronchoconstriction in asthma. Implication for symptom perception. Chest 2006;130:10721081.
  • 44
    Binks AP, Moosavi SH, Banzett RB, Schwartzstein RM. “Tightness” sensation of asthma does not arise from the work of breathing. Am J Respir Crit Care Med 2002;165:7882.
  • 45
    Moy ML, Woodrow Weiss J, Sparrow D, Israel E, Schwartzstein RM. Quality of dyspnea in bronchoconstriction differs from external resistive loads. Am J Respir Crit Care Med 2000;162(2 Pt 1):451455.
  • 46
    Manning HL, Mahler DA. Pathophysiology of dyspnea. Monaldi Arch Chest Dis 2001;56:325330.
  • 47
    Undem BJ, Carr MJ. Pharmacology of airway afferent nerve activity. Respir Res 2001;2:234244.
  • 48
    Killian KJ, Watson R, Otis J, St Amand TA, O'Byrne PM. Symptom perception during acute bronchoconstriction. Am J Respir Crit Care Med 2000;162(2 Pt 1):490496.
  • 49
    Taguchi O, Kikuchi Y, Hida W, Iwase N, Okabe S, Chonan T et al. Prostaglandin E2 inhalation increases the sensation of dyspnea during exercise. Am Rev Respir Dis 1992;145:13461349.
  • 50
    Tetzlaff K, Leplow B, Ten Thoren C, Dahme B. Perception of dyspnea during histamine- and methacholine-induced bronchoconstriction. Respiration 1999;66:427433.
  • 51
    Undem BJ, Carr MJ. The role of nerves in asthma. Curr Allergy Asthma Rep 2002;2:159165.
  • 52
    Banzett RB, Lansing RW, Reid MB, Adams L, Brown R. ‘Air hunger’ arising from increased PCO2 in mechanically ventilated quadriplegics. Respir Physiol 1989;76:5367.
  • 53
    Banzett RB, Lansing RW, Brown R, Topulos GP, Yager D, Steele SM et al. ‘Air hunger’ from increased PCO2 persists after complete neuromuscular block in humans. Respir Physiol 1990;81:117.
  • 54
    Lowhagen O. [Functional respiratory disorders as significant differential diagnosis in asthma]. Lakartidningen 1989;86:5759. Funktionella andningsbesvar viktig differentialdiagnos vid astma.
  • 55
    Ringsberg KC, Lowhagen O, Sivik T. Psychological differences between asthmatics and patients suffering from an asthma-like condition, functional breathing disorder: a comparison between the two groups concerning personality, psychosocial and somatic parameters. Integr Physiol Behav Sci 1993;28:358367.
  • 56
    Millqvist E, Bende M, Lowhagen O. Sensory hyperreactivity–a possible mechanism underlying cough and asthma-like symptoms. Allergy 1998;53:12081212.
  • 57
    Lowhagen O. Asthma and asthma-like disorders. Respir Med 1999;93:851855.
  • 58
    Grossman P, de Swart JC. Diagnosis of hyperventilation syndrome on the basis of reported complaints. J Psychosom Res 1984;28:97104.
  • 59
    Gardner WN. The pathophysiology of hyperventilation disorders. Chest 1996;109:516534.
  • 60
    Folgering H. The pathophysiology of hyperventilation syndrome. Monaldi Arch Chest Dis 1999;54:365372.
  • 61
    Lowhagen O, Arvidsson M, Bjarneman P, Jorgensen N. Exercise-induced respiratory symptoms are not always asthma. Respir Med 1999;93:734738.
  • 62
    Ternesten-Hasseus E, Johansson EL, Bende M, Millqvist E. Dyspnea from exercise in cold air is not always asthma. J Asthma 2008;45:705709.
  • 63
    Bass C. Hyperventilation syndrome: a chimera? J Psychosom Res 1997;42:421426.
  • 64
    Hornsveld H, Garssen B. Hyperventilation syndrome: an elegant but scientifically untenable concept. Neth J Med 1997;50:1320.
  • 65
    Brightling CE. Cough due to asthma and nonasthmatic eosinophilic bronchitis. Lung 2010;188(Suppl 1):S13S17.
  • 66
    Brightling CE. Eosinophils, bronchitis and asthma: pathogenesis of cough and airflow obstruction. Pulm Pharmacol Ther 2011;24:324327.
  • 67
    Keeley D, Osman L. Dysfunctional breathing and asthma. It is important to tell the difference. BMJ 2001;322:10751076.
  • 68
    Thomas M, McKinley RK, Freeman E, Foy C, Prodger P, Price D. Breathing retraining for dysfunctional breathing in asthma: a randomised controlled trial. Thorax 2003;58:110115.
  • 69
    Thomas M, McKinley RK, Freeman E, Foy C, Price D. The prevalence of dysfunctional breathing in adults in the community with and without asthma. Prim Care Respir J 2005;14:7882.
  • 70
    Thomas M, Bruton A, Moffat M, Cleland J. Asthma and psychological dysfunction. Prim Care Respir J 2011;20:250256.
  • 71
    Ternesten-Hasseus E, Bende M, Millqvist E. Increased capsaicin cough sensitivity in patients with multiple chemical sensitivity. J Occup Environ Med 2002;44:10121017.
  • 72
    Holst H, Arendt-Nielsen L, Mosbech H, Vesterhauge S, Elberling J. The capsaicin cough reflex in patients with symptoms elicited by odorous chemicals. Int J Hyg Environ Health 2010;213:6671.
  • 73
    Millqvist E. Cough provocation with capsaicin is an objective way to test sensory hyperreactivity in patients with asthma-like symptoms. Allergy 2000;55:546550.
  • 74
    Johansson A, Lowhagen O, Millqvist E, Bende M. Capsaicin inhalation test for identification of sensory hyperreactivity. Respir Med 2002;96:731735.
  • 75
    Nordin S, Millqvist E, Lowhagen O, Bende M. A short Chemical Sensitivity Scale for assessment of airway sensory hyperreactivity. Int Arch Occup Environ Health 2004;77:249254.
  • 76
    Andersson L, Johansson A, Millqvist E, Nordin S, Bende M. Prevalence and risk factors for chemical sensitivity and sensory hyperreactivity in teenagers. Int J Hyg Environ Health 2008;211:690697.
  • 77
    Johansson A, Millqvist E, Bende M. Relationship of airway sensory hyperreactivity to asthma and psychiatric morbidity. Ann Allergy Asthma Immunol 2010;105:2023.
  • 78
    Lotvall J, Ekerljung L, Ronmark EP, Wennergren G, Linden A, Ronmark E et al. West Sweden Asthma Study: prevalence trends over the last 18 years argues no recent increase in asthma. Respir Res 2009;10:94.
  • 79
    McClean PA, Howells JCG, Boyd G. Use of Nijmegen hyperventilation questionnaire and hyperventilation provocation in a hospital asthma clinic. Am J Respir Crit Care Med 1999;159:A652.
  • 80
    Ternesten-Hasseus E, Lowhagen O, Millqvist E. Quality of life and capsaicin sensitivity in patients with airway symptoms induced by chemicals and scents: a longitudinal study. Environ Health Perspect 2007;115:425429.
  • 81
    Ringsberg KC, Segesten K, Akerlind I. Walking around in circles–the life situation of patients with asthma-like symptoms but negative asthma tests. Scand J Caring Sci 1997;11:103112.
  • 82
    Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011;66:910917.
  • 83
    Ternesten-Hasseus E, Larsson C, Bende M, Millqvist E. Capsaicin provocation using two different inhalation devices. Respir Med 2008;102:17841790.